Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Richmond American Announces Grand Opening in Monument
-
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against AXT, Inc. (AXTI)
-
Exco Technologies Limited Announces Second Quarter Results on May 1, 2024
-
Melbourne public transport services sit idle while apartment numbers boom
-
Dundee Precious Metals Delivers Strong First Quarter Gold Production; Announces Timing of First Quarter Financial Results
-
Peapack Private Announces New York City Expansion
-
Wheaton Precious Metals to Release 2024 First Quarter Results on May 9, 2024
-
White Cap Expands Rebar Operations with Acquisition of Crimson Steel Supply, LLC
-
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
-
Independence Realty Trust Announces First Quarter 2024 Earnings Release and Conference Call Dates
-
Brunswick Signs Right to Repurchases 0.5% NSR on Select Claims at Mirage
-
SoFi Schedules 2024 Annual Meeting of Stockholders
-
Pinnacle Financial Partners Announces Dates for First Quarter 2024 Earnings Release and Conference Call
-
Sirios grants Brunswick right to purchase a royalty on select claims of the Mirage Property
-
CONTINUOUS AUTONOMOUS CONNECTIVITY FOR WAREHOUSE ROBOTICS ACHIEVED
-
NRSInsights’ March 2024 Retail Same-Store Sales Report
-
Falling Colors To Continue as ASO Following State's Request For Proposals
-
Convocation of the ordinary general shareholders meeting of Invalda INVL
-
Atlas Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer p
-
ROSEN, A LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
-
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
-
CO2 GRO Inc. Announces the Commissioning of Its Largest Global Commercial Project with Hidroexpo
-
Chicago Atlantic Closes $20 Million Facility with Nova Farms
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTYX
-
Norfolk Southern to participate in fireside chat with Wolfe Research
-
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
-
Cantargia presents unique effects of nadunolimab in pancreatic cancer
-
Margex Expands Trading Options with Addition of Four New USDT Pairs
-
Phanes Therapeutics' PT217 granted Fast Track Designation by the FDA
-
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For March 2024
-
Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023
-
NOTICE TO DISREGARD -- LeaseQuery
-
Qalby Etmaan in Gaza
-
Believe It or Not! Total Solar Eclipse Captured for Ripley’s Exhibit Collection
-
Verita announces claims leadership team
-
Southwest Gas Announces Launch of Centuri Initial Public Offering Roadshow
-
Certain DWS Closed-End Funds Declare Monthly Distributions
-
Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)
-
Cathie Biga is New American College of Cardiology President
-
Cabot Corporation to Announce Second Quarter 2024 Operating Results
-
Spetz Enhances Cash Flow with Debt Conversion Plan
-
Trumpeter/Composer Etienne Charles Debuts as a Big Band Leader with "Creole Orchestra," Arriving June 14 on Culture Shock Records
-
Mandalay Resources Corporation Announces Strong Production Results and Growing Cash Balance for First Quarter 2024
-
Stratasys Elevates Customer Service and Operations, Welcoming a New COO
-
Enviva Receives NYSE Notice Regarding Delayed Form 10-K Filing
-
Harmonic Announces CEO Succession
-
ASUR Announces Total Passenger Traffic for March 2024
-
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Exai Bio to Present New Breast Cancer Data at the American Association for Cancer Research (AACR) 2024 Annual Meeting

